Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_provenance.
- NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_assertion wasGeneratedBy ECO_0000203 NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_provenance.
- NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_assertion wasDerivedFrom befree-20140225 NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_provenance.
- NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_assertion SIO_000772 17091508 NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_provenance.
- NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_assertion evidence source_evidence_literature NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_provenance.
- NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_assertion description "[Published FDA-validated HPV testing follow-up data show that the expected rates of CIN III+ and CIN II+ in the HPV-negative ASC-US population are 1.4% and 5%, respectively, with PPV/NPVs (CIN II+) of 20%/99%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP281170.RA_WNv6tSnBtTDAY_jz-smF0w4OC-CoKslR5GJ0yW8QPM130_provenance.